Over a month ago
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/17/23 XPeng rises 10.8% 03/17/23 XPeng announces 5,218 vehicles delivered in January 03/10/23 XPeng laiuches P7i sports sedan in China 03/01/23 XPeng delivers 6,010 Smart EVs in February 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Fly Intel: Top five weekend stock stories 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/22/23 Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer 03/13/23 Nano Dimension CEO provides rationale for acquisition of Stratasys 03/24/23 Block continues selloff, shares down 4% to $59.31 03/23/23 Cathie Wood's ARK Investment bought 338K shares of Block today 03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 03/23/23 Stifel Financial announces significant expansion of venture banking business 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/22/23 Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate 03/20/23 WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank 03/24/23 Stifel Financial co-president Zemlyak buys 20,000 common shares 03/01/23 Stifel Financial closes acquisition of Torreya partners 02/16/23 Stifel Financial announces launch of an ASPG, new hires 03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 02/13/23 ReNew Energy to rebrand as ReNew 12/16/22 ReNew Energy Global signs 150 MW agreement with Microsoft $820.34 / +17.72 (+2.21%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/24/23 Pharming up 22% after resuming trading following announcement of FDA approval 03/24/23 Pharming up 7% after FDA approves Joenja for APDS 03/24/23 Pharming announces FDA approval of Joenja 02/21/23 Pharming announces first patient enrolled in leniolisib trial 03/24/23 Oncorus expects cash to fund expenditures into early 2024 03/10/23 Oncorus informs investors of holdings with SVB Financial 01/04/23 Oncorus announces research collaboration with Daewoong Pharmaceutical 11/30/22 Oncorus announces reprioritization of lead product candidate ONCR-021 03/23/23 Nano Dimension to review options relative to Stratasys and alternative targets 03/23/23 Nano Dimension releases video on products, materials, technologies 03/22/23 Stratasys board unanimously rejects acquisition proposal from Nano Dimension 03/21/23 Nano Dimension responds to Murchinson claims about shareholder meeting results 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML 03/21/23 Nvidia says Nvidia Omniverse Cloud now available to select enterprises 03/06/23 Altria Group to acquire NJOY Holdings for $2.75B in cash 03/03/23 Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights 01/24/23 Altria Group trading resumes 01/24/23 Altria Group trading halted, volatility trading pause $205.99 / +1.695 (+0.83%)
03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning 03/16/23 Leap Therapeutics provides update on BeiGene option agreement for DKN-01 01/17/23 Leap Therapeutics acquires Flame Biosciences 11/07/22 Leap Therapeutics' DKN-01 demonstrates preclinical tumor regression in study 10/17/22 Leap Therapeutics enrolls first patient in study of colorectal cancer candidate 03/22/23 JPMorgan to acquire Aumni, terms not disclosed 03/21/23 Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market 03/16/23 First Republic confirms it will receive deposits totaling $30B from banks 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023 03/24/23 Impel Pharmaceuticals expects cash to fund operations into 3Q23 02/22/23 Impel Pharmaceuticals announces strategic reprioritization, departure of CMO 09/28/22 Impel Pharmaceuticals Inc trading resumes 03/24/23 Humacyte expects cash to fund operations through 2024 01/24/23 Humacyte announces publication of 6-year outcomes in Phase 2 study of HAV 12/13/22 Humacyte hosts KOL webinar on vascular trauma 11/10/22 Humacyte expects cash to fund operations through 2024 03/24/23 Farfetch falls -8.1% 02/24/23 Farfetch rises 13.0% 02/23/23 Farfetch CFO Jordan to step down by end of 2023 01/18/23 Farfetch announces changes to leadership team 03/24/23 Deutsche Bank falls -6.7% 03/24/23 Deutsche Bank falls -6.5% 03/22/23 Deutsche Bank raises prime lending rate to 8.00% from 7.75%, effective March 23 02/02/23 Deutsche Bank reaffirms financial targets for 2025 03/23/23 Cathie Wood's ARK Investment bought 269K shares of Coinbase today 03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 02/03/23 Clorox rises 9.6% 02/02/23 Clorox sees FX headwinds a 2-point reduction to FY23 sales 02/02/23 Clorox CEO says 'actions we are taking to rebuild margin are working' 02/02/23 Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago 03/16/23 Fed, Treasury say banks' deposits in First Republic show system's 'resilience' 03/16/23 Group of banks confirm plan to make deposits totaling $30B in First Republic 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Microsoft signs 10-year Xbox PC game partnership with Ubitus 03/14/23 Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February AMPX Amprius Technologies 03/24/23 Amprius Technologies falls -8.0% 03/24/23 Amprius Technologies rises 6.8% 03/23/23 Amprius Technologies says will be 'limited by manufacturing capacity' 03/06/23 Amprius Technologies selects Colorado for new facility 03/02/23 Yield10 Bioscience, American Airlines sign MOU to form collaboration 02/23/23 American Airlines chairman Doug Parker to retire, Greg Smith to succeed 02/08/23 American Airlines announces proposed offering of senior secured notes 01/26/23 American Airlines sees delivery of 17 737 Max 8s in 2023 02/10/23 BofA Deutsche Bank downgraded to Underperform from Neutral at BofA 02/08/23 UBS Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS 02/03/23 Credit Suisse Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse 01/13/23 Barclays Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays 11/10/22 UBS UBS downgrades Altria to Sell on consumer trade down risk 11/10/22 UBS Altria Group downgraded to Sell from Neutral at UBS 11/02/22 Morgan Stanley Philip Morris price target raised to $109 from $102 at Morgan Stanley 10/28/22 Stifel Altria JV news trumps 'rare' EPS miss, says Stifel 03/20/23 Deutsche Bank Clorox price target lowered to $147 from $152 at Deutsche Bank 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Clorox initiated with a Neutral at Citi 02/06/23 Barclays Clorox price target lowered to $108 from $110 at Barclays 03/24/23 Loop Capital Joann price target lowered to $2 from $4 at Loop Capital 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/20/23 Morgan Stanley XPeng price target raised to $12.50 from $12 at Morgan Stanley 03/20/23 Morgan Stanley Li Auto price target raised to $30 from $23 at Morgan Stanley $820.34 / +17.72 (+2.21%)
03/24/23 BMO Capital Regeneron price target raised to $1,040 from $1,025 at BMO Capital 03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/24/23 RBC Capital JPMorgan price target lowered to $132 from $150 at RBC Capital 03/13/23 Wells Fargo Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme 03/13/23 Wells Fargo JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo 02/24/23 Morgan Stanley JPMorgan price target raised to $173 from $167 at Morgan Stanley 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA 03/20/23 Benchmark Aspen Aerogels upgraded to Buy from Hold at Benchmark $205.99 / +1.695 (+0.83%)
03/24/23 JPMorgan Meta Platforms price target raised to $270 from $225 at JPMorgan 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/17/23 Wolfe Research American Airlines upgraded to Peer Perform from Underperform at Wolfe Research 03/17/23 Wolfe Research American Airlines upgraded to Peer Perform from Underperform at Wolfe Research 03/10/23 Barclays American Airlines price target raised to $15 from $14 at Barclays 03/07/23 Evercore ISI Delta Air Lines upgraded to Outperform from In Line at Evercore ISI 03/24/23 RBC Capital Bank of America price target lowered to $34 from $40 at RBC Capital 03/08/23 Odeon Capital Bank of America downgraded to Hold from Buy at Odeon Capital 02/08/23 Keefe Bruyette Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform 02/08/23 Keefe Bruyette Bank of America downgraded to Underperform at Keefe Bruyette 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street 03/03/23 Lake Street Stratasys price target raised to $22 from $20 at Lake Street 01/04/23 Needham Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023 01/04/23 Needham Stratasys upgraded to Buy from Hold at Needham 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 02/16/23 Deutsche Bank Deutsche upgrades Activision to Buy, says best risk/reward in gaming 02/16/23 Deutsche Bank Activision Blizzard upgraded to Buy from Hold at Deutsche Bank 02/10/23 Roth MKM Activision Blizzard price target lowered to $88 from $95 at Roth MKM 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/20/23 Evercore ISI Microsoft price target raised to $295 from $280 at Evercore ISI 03/17/23 Mizuho Microsoft price target raised to $315 from $300 at Mizuho AMPX Amprius Technologies 12/02/22 B. Riley B. Riley starts 'early battery winner' Amprius with Buy, $14 target 12/01/22 B. Riley Amprius Technologies initiated with a Buy at B. Riley 10/27/22 EF Hutton Amprius Technologies initiated with a Buy at EF Hutton 10/13/22 Oppenheimer Amprius Technologies initiated with an Outperform at Oppenheimer 03/24/23 Citi Farfetch price target lowered to $4 from $6 at Citi 03/24/23 JMP Securities Farfetch initiated with a Market Perform at JMP Securities 01/30/23 KeyBanc KeyBanc keeps Overweight on Farfetch, lowers price target to $11 12/15/22 Oppenheimer Farfetch price target lowered to $7 from $14 at Oppenheimer IMPL Impel Pharmaceuticals 11/15/22 Wedbush Wedbush downgrades Impel Pharmaceuticals to Neutral, lowers price target to $5 11/15/22 Wedbush Impel Pharmaceuticals downgraded to Neutral from Outperform at Wedbush 08/24/22 JonesResearch Impel Pharmaceuticals initiated with a Buy at JonesTrading 01/12/23 Citi Stifel Financial price target raised to $65 from $60 at Citi 01/10/23 JMP Securities Stifel Financial price target lowered to $95 from $98 at JMP Securities 11/22/22 UBS Stifel Financial initiated with a Neutral at UBS 10/12/22 Citi Citi starts exchanges and brokers with CME, MarketAxess among top picks 12/06/22 H.C. Wainwright Oncorus downgraded to Neutral from Buy at H.C. Wainwright 11/30/22 Chardan Oncorus downgraded to Neutral from Buy at Chardan 11/30/22 Piper Sandler Piper downgrades Oncorus with plug pulled on lead program 11/30/22 Piper Sandler Oncorus downgraded to Neutral from Overweight at Piper Sandler 03/17/23 Piper Sandler Leap Therapeutics news 'disappointing at first glance,' says Piper Sandler 03/17/23 Mizuho Leap Therapeutics price target lowered to $2 from $3 at Mizuho 01/27/23 Mizuho Leap Therapeutics price target lowered to $3 from $6 at Mizuho 01/17/23 Piper Sandler Leap Therapeutics price target lowered to $3 from $4 at Piper Sandler 03/12/23 BTIG BTIG finds medical technology stocks with exposure with SVB 12/19/22 TD Cowen Humacyte price target lowered to $5 from $8 at Cowen 11/10/22 Piper Sandler Humacyte price target lowered to $2.75 from $3.50 at Piper Sandler 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 03/17/23 XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M 03/17/23 XPeng reports Q4 adjusted EPS (37c), consensus (36c) 11/30/22 XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B 11/30/22 XPeng reports Q3 EPS (36c), consensus (36c) 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 Stratasys sees FY23 EPS 12c-24c, consensus 20c 03/02/23 Stratasys reports Q4 EPS 7c, consensus 3c 11/10/22 Stratasys sees FY22 EPS 9c-12c, consensus 14c 02/23/23 Block reports Q4 EPS 22c, consensus 30c 02/23/23 Notable companies reporting after market close 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 03/24/23 Stifel Financial sees Q1 investment banking revenue down 5%-10% from Q4 01/25/23 Stifel Financial reports Q4 adjusted EPS $1.58, consensus $1.64 10/26/22 Stifel Financial reports Q3 adjusted EPS $1.29, consensus $1.45 03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago $820.34 / +17.72 (+2.21%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/24/23 Oncorus reports Q4 EPS (81c), consensus (76c) 11/02/22 Oncorus reports Q3 EPS (76c), consensus (75c) 01/24/23 Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21 12/01/22 Nano Dimension reports Q3 EPS (26c) vs. (7c) last year 10/24/22 Nano Dimension sees Q3 revenue $10M 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 03/23/23 Altria Group affirms FY23 EPS view of $4.98-$5.13, consensus $5.06 02/01/23 Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05 02/01/23 Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17 01/31/23 Notable companies reporting before tomorrow's open $205.99 / +1.695 (+0.83%)
02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 03/24/23 Leap Therapeutics reports Q4 EPS (11c), consensus (11c) 11/14/22 Leap Therapeutics reports Q3 EPS (13c), consensus (12c) 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 01/12/23 Notable companies reporting before tomorrow's open 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11) 11/14/22 Impel Pharmaceuticals reports Q3 EPS ($1.31), consensus ($1.00) 03/24/23 Humacyte reports Q4 EPS (4c), consensus (23c) 11/10/22 Humacyte reports Q3 EPS (25c), consensus (21c) 02/23/23 Farfetch sees FY23 adjusted EBITDA margin 1%-3% 02/23/23 Farfetch reports Q4 adjusted EPS (25c), consensus (47c) 11/17/22 Farfetch reports Q3 adjusted EPS (24c), consensus (28c) 02/02/23 Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year 10/26/22 Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B 10/26/22 Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B 02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 02/02/23 Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22 02/02/23 Clorox reports Q2 adjusted EPS 98c, consensus 65c 02/02/23 Notable companies reporting after market close 11/01/22 Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07 01/13/23 Bank of America reports Q4 EPS 85c, consensus 77c 10/17/22 Bank of America reports Q3 EPS 81c, consensus 77c 02/06/23 Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51 02/06/23 Notable companies reporting after market close 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close AMPX Amprius Technologies 03/23/23 Amprius Technologies reports Q4 EPS (7c), consensus (6c) 01/26/23 American Airlines sees Q1 adjusted EPS approx. breakeven, consensus 1c 01/26/23 American Airlines sees 2023 adjusted EPS $2.50-$3.50, consensus $1.77 01/26/23 American Airlines reports Q4 EPS ex-items $1.17, consensus $1.14 01/25/23 Notable companies reporting before tomorrow's open
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/17/23 XPeng rises 10.8% 03/17/23 XPeng announces 5,218 vehicles delivered in January 03/10/23 XPeng laiuches P7i sports sedan in China 03/01/23 XPeng delivers 6,010 Smart EVs in February 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/22/23 Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer 03/13/23 Nano Dimension CEO provides rationale for acquisition of Stratasys 03/24/23 Block continues selloff, shares down 4% to $59.31 03/23/23 Cathie Wood's ARK Investment bought 338K shares of Block today 03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 03/23/23 Stifel Financial announces significant expansion of venture banking business 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/22/23 Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate 03/20/23 WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank 03/01/23 Stifel Financial closes acquisition of Torreya partners 02/16/23 Stifel Financial announces launch of an ASPG, new hires 01/31/23 Eaton Partners acts as exclusive placement agent for SKY Leasing Fund V $31.15 / -10.14 (-24.56%)
03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 02/13/23 ReNew Energy to rebrand as ReNew 12/16/22 ReNew Energy Global signs 150 MW agreement with Microsoft 03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/24/23 Oncorus expects cash to fund expenditures into early 2024 03/10/23 Oncorus informs investors of holdings with SVB Financial 01/04/23 Oncorus announces research collaboration with Daewoong Pharmaceutical 11/30/22 Oncorus announces reprioritization of lead product candidate ONCR-021 03/23/23 Nano Dimension to review options relative to Stratasys and alternative targets 03/23/23 Nano Dimension releases video on products, materials, technologies 03/22/23 Stratasys board unanimously rejects acquisition proposal from Nano Dimension 03/21/23 Nano Dimension responds to Murchinson claims about shareholder meeting results 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML 03/21/23 Nvidia says Nvidia Omniverse Cloud now available to select enterprises 03/06/23 Altria Group to acquire NJOY Holdings for $2.75B in cash 03/03/23 Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights 01/24/23 Altria Group trading resumes 01/24/23 Altria Group trading halted, volatility trading pause $205.93 / +1.635 (+0.80%)
03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning 03/16/23 Leap Therapeutics provides update on BeiGene option agreement for DKN-01 01/17/23 Leap Therapeutics acquires Flame Biosciences 11/07/22 Leap Therapeutics' DKN-01 demonstrates preclinical tumor regression in study 10/17/22 Leap Therapeutics enrolls first patient in study of colorectal cancer candidate 03/22/23 JPMorgan to acquire Aumni, terms not disclosed 03/21/23 Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market 03/19/23 Fly Intel: Top five weekend stock stories 03/16/23 First Republic confirms it will receive deposits totaling $30B from banks 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023 03/24/23 Impel Pharmaceuticals expects cash to fund operations into 3Q23 02/22/23 Impel Pharmaceuticals announces strategic reprioritization, departure of CMO 09/28/22 Impel Pharmaceuticals Inc trading resumes 03/24/23 Humacyte expects cash to fund operations through 2024 01/24/23 Humacyte announces publication of 6-year outcomes in Phase 2 study of HAV 12/13/22 Humacyte hosts KOL webinar on vascular trauma 11/10/22 Humacyte expects cash to fund operations through 2024 03/24/23 Farfetch falls -8.1% 02/24/23 Farfetch rises 13.0% 02/23/23 Farfetch CFO Jordan to step down by end of 2023 01/18/23 Farfetch announces changes to leadership team 03/24/23 Deutsche Bank falls -6.7% 03/24/23 Deutsche Bank falls -6.5% 03/22/23 Deutsche Bank raises prime lending rate to 8.00% from 7.75%, effective March 23 02/02/23 Deutsche Bank reaffirms financial targets for 2025 03/02/23 Salesforce rises 11.8% 03/02/23 Salesforce rises 13.4% 03/02/23 Salesforce rises 14.2% 03/01/23 Elliott says Salesforce's announcements represent 'progress' 03/23/23 Cathie Wood's ARK Investment bought 269K shares of Coinbase today 03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 02/03/23 Clorox rises 9.6% 02/02/23 Clorox sees FX headwinds a 2-point reduction to FY23 sales 02/02/23 Clorox CEO says 'actions we are taking to rebuild margin are working' 02/02/23 Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Microsoft signs 10-year Xbox PC game partnership with Ubitus 03/14/23 Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February AMPX Amprius Technologies 03/24/23 Amprius Technologies falls -8.0% 03/24/23 Amprius Technologies rises 6.8% 03/23/23 Amprius Technologies says will be 'limited by manufacturing capacity' 03/06/23 Amprius Technologies selects Colorado for new facility 03/14/23 Apple launches Shop with a Specialist over Video 03/09/23 Apple says Apple Music Classical releases March 28 03/08/23 Apple backs new music startup Gamma 03/07/23 Sonos to add support for spatial audio on Apple Music 02/10/23 BofA Deutsche Bank downgraded to Underperform from Neutral at BofA 02/08/23 UBS Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS 02/03/23 Credit Suisse Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse 01/13/23 Barclays Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays 11/10/22 UBS UBS downgrades Altria to Sell on consumer trade down risk 11/10/22 UBS Altria Group downgraded to Sell from Neutral at UBS 11/02/22 Morgan Stanley Philip Morris price target raised to $109 from $102 at Morgan Stanley 10/28/22 Stifel Altria JV news trumps 'rare' EPS miss, says Stifel 03/20/23 Deutsche Bank Clorox price target lowered to $147 from $152 at Deutsche Bank 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Clorox initiated with a Neutral at Citi 02/06/23 Barclays Clorox price target lowered to $108 from $110 at Barclays $31.15 / -10.14 (-24.56%)
03/24/23 Loop Capital Joann price target lowered to $2 from $4 at Loop Capital 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 03/24/23 RBC Capital JPMorgan price target lowered to $132 from $150 at RBC Capital 03/13/23 Wells Fargo Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme 03/13/23 Wells Fargo JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo 02/24/23 Morgan Stanley JPMorgan price target raised to $173 from $167 at Morgan Stanley 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA 03/20/23 Benchmark Aspen Aerogels upgraded to Buy from Hold at Benchmark $205.93 / +1.635 (+0.80%)
03/24/23 JPMorgan Meta Platforms price target raised to $270 from $225 at JPMorgan 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/16/23 Susquehanna Qualcomm upgraded at Susquehanna with China opening, Apple 'de-risked' 03/14/23 Evercore ISI Apple premium to big tech 'justified,' could expand further, says Evercore ISI 03/10/23 LightShed Partners Apple cut to Sell at LightShed on more conservative outlook for iPhone sales 03/09/23 Needham Vertex price target raised to $25 from $19 at Needham 03/03/23 Citi Salesforce price target raised to $210 from $182 at Citi 03/02/23 BMO Capital Salesforce price target raised to $230 from $185 at BMO Capital 03/02/23 Truist Salesforce price target raised to $250 from $210 at Truist 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street 03/03/23 Lake Street Stratasys price target raised to $22 from $20 at Lake Street 01/04/23 Needham Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023 01/04/23 Needham Stratasys upgraded to Buy from Hold at Needham 02/16/23 Deutsche Bank Deutsche upgrades Activision to Buy, says best risk/reward in gaming 02/16/23 Deutsche Bank Activision Blizzard upgraded to Buy from Hold at Deutsche Bank 02/10/23 Roth MKM Activision Blizzard price target lowered to $88 from $95 at Roth MKM 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/20/23 Evercore ISI Microsoft price target raised to $295 from $280 at Evercore ISI 03/17/23 Mizuho Microsoft price target raised to $315 from $300 at Mizuho AMPX Amprius Technologies 12/02/22 B. Riley B. Riley starts 'early battery winner' Amprius with Buy, $14 target 12/01/22 B. Riley Amprius Technologies initiated with a Buy at B. Riley 10/27/22 EF Hutton Amprius Technologies initiated with a Buy at EF Hutton 10/13/22 Oppenheimer Amprius Technologies initiated with an Outperform at Oppenheimer 03/23/23 Nomura VNET Group downgraded to Neutral from Buy at Nomura 09/01/22 Credit Suisse Credit Suisse downgrades VNET Group to Neutralm lowers target to $5.90 09/01/22 Credit Suisse VNET Group downgraded to Neutral from Outperform at Credit Suisse 05/25/22 HSBC VNET Group price target lowered to $9.40 from $13.50 at HSBC 03/24/23 Citi Farfetch price target lowered to $4 from $6 at Citi 03/24/23 JMP Securities Farfetch initiated with a Market Perform at JMP Securities 01/30/23 KeyBanc KeyBanc keeps Overweight on Farfetch, lowers price target to $11 12/15/22 Oppenheimer Farfetch price target lowered to $7 from $14 at Oppenheimer IMPL Impel Pharmaceuticals 11/15/22 Wedbush Wedbush downgrades Impel Pharmaceuticals to Neutral, lowers price target to $5 11/15/22 Wedbush Impel Pharmaceuticals downgraded to Neutral from Outperform at Wedbush 08/24/22 JonesResearch Impel Pharmaceuticals initiated with a Buy at JonesTrading 01/12/23 Citi Stifel Financial price target raised to $65 from $60 at Citi 01/10/23 JMP Securities Stifel Financial price target lowered to $95 from $98 at JMP Securities 11/22/22 UBS Stifel Financial initiated with a Neutral at UBS 10/12/22 Citi Citi starts exchanges and brokers with CME, MarketAxess among top picks 12/06/22 H.C. Wainwright Oncorus downgraded to Neutral from Buy at H.C. Wainwright 11/30/22 Chardan Oncorus downgraded to Neutral from Buy at Chardan 11/30/22 Piper Sandler Piper downgrades Oncorus with plug pulled on lead program 11/30/22 Piper Sandler Oncorus downgraded to Neutral from Overweight at Piper Sandler 03/17/23 Piper Sandler Leap Therapeutics news 'disappointing at first glance,' says Piper Sandler 03/17/23 Mizuho Leap Therapeutics price target lowered to $2 from $3 at Mizuho 01/27/23 Mizuho Leap Therapeutics price target lowered to $3 from $6 at Mizuho 01/17/23 Piper Sandler Leap Therapeutics price target lowered to $3 from $4 at Piper Sandler 03/12/23 BTIG BTIG finds medical technology stocks with exposure with SVB 12/19/22 TD Cowen Humacyte price target lowered to $5 from $8 at Cowen 11/10/22 Piper Sandler Humacyte price target lowered to $2.75 from $3.50 at Piper Sandler 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/20/23 Morgan Stanley XPeng price target raised to $12.50 from $12 at Morgan Stanley 03/20/23 Morgan Stanley Li Auto price target raised to $30 from $23 at Morgan Stanley 03/24/23 BMO Capital Regeneron price target raised to $1,040 from $1,025 at BMO Capital 03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/17/23 XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M 03/17/23 XPeng reports Q4 adjusted EPS (37c), consensus (36c) 11/30/22 XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B 11/30/22 XPeng reports Q3 EPS (36c), consensus (36c) 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 Stratasys sees FY23 EPS 12c-24c, consensus 20c 03/02/23 Stratasys reports Q4 EPS 7c, consensus 3c 11/10/22 Stratasys sees FY22 EPS 9c-12c, consensus 14c 02/23/23 Block reports Q4 EPS 22c, consensus 30c 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 03/24/23 Stifel Financial sees Q1 investment banking revenue down 5%-10% from Q4 01/25/23 Stifel Financial reports Q4 adjusted EPS $1.58, consensus $1.64 10/26/22 Stifel Financial reports Q3 adjusted EPS $1.29, consensus $1.45 $31.15 / -10.14 (-24.56%)
03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/24/23 Oncorus reports Q4 EPS (81c), consensus (76c) 11/02/22 Oncorus reports Q3 EPS (76c), consensus (75c) 01/24/23 Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21 12/01/22 Nano Dimension reports Q3 EPS (26c) vs. (7c) last year 10/24/22 Nano Dimension sees Q3 revenue $10M 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 03/23/23 Altria Group affirms FY23 EPS view of $4.98-$5.13, consensus $5.06 02/01/23 Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05 02/01/23 Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17 01/31/23 Notable companies reporting before tomorrow's open $205.93 / +1.635 (+0.80%)
02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 03/24/23 Leap Therapeutics reports Q4 EPS (11c), consensus (11c) 11/14/22 Leap Therapeutics reports Q3 EPS (13c), consensus (12c) 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 01/12/23 Notable companies reporting before tomorrow's open 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11) 11/14/22 Impel Pharmaceuticals reports Q3 EPS ($1.31), consensus ($1.00) 03/24/23 Humacyte reports Q4 EPS (4c), consensus (23c) 11/10/22 Humacyte reports Q3 EPS (25c), consensus (21c) 02/23/23 Farfetch sees FY23 adjusted EBITDA margin 1%-3% 02/23/23 Farfetch reports Q4 adjusted EPS (25c), consensus (47c) 02/23/23 Notable companies reporting after market close 11/17/22 Farfetch reports Q3 adjusted EPS (24c), consensus (28c) 02/02/23 Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year 10/26/22 Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B 10/26/22 Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B 03/01/23 Salesforce guides initial FY24 EPS $7.12-7.14, consensus $5.84 03/01/23 Salesforce sees Q1 EPS $1.60-$1.61, consensus $1.32 03/01/23 Salesforce reports Q4 EPS $1.68, consensus $1.36 03/01/23 Notable companies reporting after market close 02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 02/02/23 Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22 02/02/23 Clorox reports Q2 adjusted EPS 98c, consensus 65c 02/02/23 Notable companies reporting after market close 11/01/22 Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07 02/06/23 Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51 02/06/23 Notable companies reporting after market close 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close AMPX Amprius Technologies 03/23/23 Amprius Technologies reports Q4 EPS (7c), consensus (6c) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close
On The Fly
Check out this morning's…
Show Hide Related Items >> <<
03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 02/13/23 ReNew Energy to rebrand as ReNew 12/16/22 ReNew Energy Global signs 150 MW agreement with Microsoft 03/23/23 Oxford Industries increases quarterly cash dividend 18% to 55c per share 03/21/23 Ouster and LASE GmbH in multi-year deal to automate port operation 03/16/23 Ouster expands infrastructure programs with over 210 awarded projects 02/01/23 Ouster, Velodyne Lidar achieve guidance, announce combined board of directors 01/24/23 Velodyne Lidar has not yet reached stockholder votes required for Ouster merger 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML 03/21/23 Nvidia says Nvidia Omniverse Cloud now available to select enterprises 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day 03/13/23 Heron announces CMS granted pass-through payment status for APONVIE 03/13/23 Heron says CMS granted pass-through payment status for Aponvie 03/06/23 Heron Therapeutics announces U.S. commercial launch of APONVIE 02/22/23 Heron Therapeutics announces cooperation agreement with Rubric and Velan 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Microsoft signs 10-year Xbox PC game partnership with Ubitus 03/14/23 Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 02/16/23 Deutsche Bank Deutsche upgrades Activision to Buy, says best risk/reward in gaming 02/16/23 Deutsche Bank Activision Blizzard upgraded to Buy from Hold at Deutsche Bank 02/10/23 Roth MKM Activision Blizzard price target lowered to $88 from $95 at Roth MKM 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/20/23 Evercore ISI Microsoft price target raised to $295 from $280 at Evercore ISI 03/17/23 Mizuho Microsoft price target raised to $315 from $300 at Mizuho 03/24/23 Loop Capital Joann price target lowered to $2 from $4 at Loop Capital 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 03/24/23 Evercore ISI Heron Therapeutics price target lowered to $10 from $15 at Evercore ISI 06/15/22 Evercore ISI Crinetics added to Best SMID 'Core' Ideas list at Evercore ISI 05/10/22 Cantor Fitzgerald Heron Therapeutics price target lowered to $12 from $20 at Cantor Fitzgerald 05/10/22 TD Cowen Heron Therapeutics price target lowered to $7.50 from $13 at Cowen 03/24/23 Cantor Fitzgerald Ouster price target lowered to $3 from $5 at Cantor Fitzgerald 12/07/22 Citi Ouster downgraded to Neutral from Buy at Citi 11/09/22 Oppenheimer Velodyne Lidar downgraded to Perform from Outperform at Oppenheimer 11/09/22 Craig-Hallum Velodyne Lidar upgraded to Hold from Sell at Craig-Hallum 01/30/23 KeyBanc Oxford Industries price target raised to $130 from $125 at KeyBanc 12/08/22 CL King Oxford Industries price target raised to $140 from $137 at CL King 12/08/22 Citi Oxford Industries price target raised to $110 from $105 at Citi 09/21/22 Citi Oxford Industries upgraded to Neutral from Sell at Citi 03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago 03/23/23 Oxford Industries sees FY23 adjusted EPS $11.50-$11.90, consensus $11.82 03/23/23 Oxford Industries sees Q1 adjusted EPS $3.60-$3.80, consensus $4.10 03/23/23 Oxford Industries reports Q4 adjusted EPS $2.28, consensus 12/07/22 Oxford raises FY22 adjusted EPS view to $10.60-$10.75 from $10.25-$10.60 03/23/23 Ouster sees Q1 revenue $15M-$17M, consensus $20.1M 03/23/23 Ouster reports Q4 EPS (23c), consensus (18c) 11/07/22 Ouster backs FY22 revenue view $40M-$55M, consensus $46.14M 11/07/22 Ouster reports Q3 EPS (20c), consensus (17c) 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c 03/23/23 Heron Therapeutics reports Q4 EPS (17c), consensus (28c) 11/08/22 Heron Therapeutics reports Q3 EPS (38c), consensus (38c) 02/06/23 Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51 02/06/23 Notable companies reporting after market close 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close 03/24/23 CPPIB explores buying out ReNew Energy shareholders, Bloomberg says 03/22/23 Microsoft launches preview of Microsoft Loop, Verge reports 03/22/23 Microsoft says a decade enough time for Sony to make 'COD' alternative, VGC says 03/21/23 Judge dismisses gamer suit against Microsoft over Activision deal, Reuters says 03/21/23 'WWE 2K23' passes 'Hogwarts Legacy' in U.K. boxed charts, GI.biz reports 03/20/23 Microsoft's EU remedies focus only on cloud gaming services, Reuters says 03/23/23 Fly Intel: After-Hours Movers 12/07/22 Fly Intel: After-Hours Movers 11/14/22 What You Missed This Week in EVs and Clean Energy 11/07/22 What You Missed On Wall Street On Monday 11/07/22 What You Missed On Wall Street This Morning 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/16/23 What You Missed On Wall Street This Morning 12/12/22 Fly Intel: After-Hours Movers 03/21/23 What You Missed This Week in Video Games 03/14/23 What You Missed This Week in Video Games 03/07/23 What You Missed This Week in Video Games 03/03/23 What You Missed On Wall Street On Friday 11/15/22 ReNew Energy Global PLC options imply 6.1% move in share price post-earnings 03/17/23 Early notable gainers among liquid option names on March 17th 03/17/23 Unusually active option classes on open March 17th 03/07/23 Microsoft put buyer realizes 3% same-day gains 02/13/23 Early notable gainers among liquid option names on February 13th 12/19/22 Largest borrow rate increases among liquid names 12/12/22 JOANN options imply 19.6% move in share price post-earnings 03/20/23 Activision Blizzard put volume heavy and directionally bearish 02/08/23 Unusually active option classes on open February 8th 02/06/23 Activision Blizzard options imply 6.7% move in share price post-earnings 02/03/23 Downside put Buyer in Activision Blizzard
On The Fly
Show Hide Related Items >> <<
03/23/23 Carl Icahn increases stake in Southwest Gas by $31.6M 03/14/23 Carl Icahn increases stake in Southwest Gas by $32M 03/10/23 Icahn Enterprises raises Southwest Gas stake to 12.64% from 9.9% 12/15/22 Williams to acquire MountainWest from Southwest Gas for $1.5B 03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M RLMD Relmada Therapeutics 01/09/23 Relmada Therapeutics names Cedric O'Gorman MD as Chief Medical Officer 12/07/22 Relmada Therapeutics trading resumes 12/07/22 Relmada Therapeutics' REL-1017 in depressive disorder did not reach endpoint 12/07/22 Relmada Therapeutics trading halted, news pending 12/12/22 Regulus announces resignation of board member 11/29/22 Regulus adds Rekha Garg and Claire Padgett to scientific leadership team 11/02/22 Regulus doses first patient in Phase 1b MAD study of RGSL8429 10/12/22 Quest Resource appoints Brett Johnston as CFO 03/23/23 Oxford Industries increases quarterly cash dividend 18% to 55c per share 03/21/23 Ouster and LASE GmbH in multi-year deal to automate port operation 03/16/23 Ouster expands infrastructure programs with over 210 awarded projects 02/01/23 Ouster, Velodyne Lidar achieve guidance, announce combined board of directors 01/24/23 Velodyne Lidar has not yet reached stockholder votes required for Ouster merger 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day 03/13/23 Heron announces CMS granted pass-through payment status for APONVIE 03/13/23 Heron says CMS granted pass-through payment status for Aponvie 03/06/23 Heron Therapeutics announces U.S. commercial launch of APONVIE 02/22/23 Heron Therapeutics announces cooperation agreement with Rubric and Velan 12/20/22 Erasca announces first patient dosed in HERKULES-1 Phase 1b trial 12/13/22 Erasca announces FDA clearance of IND application for ERAS-3490 12/09/22 Erasca announces pricing of underwritten offering of common stock 12/09/22 Erasca, Novartis enter worldwide license agreement for naporafenib 02/06/23 Nasdaq confirms Eargo's minimum bid price deficiency 'cured' 01/11/23 Eargo announces 1-for-20 reverse stock split 01/11/23 Eargo to complete a 1-for-20 reverse stock split 12/12/22 Eargo to partner with NationsBenefits on over-the-counter hearing aids 02/06/23 Cyteir Therapeutics promotes David Gaiero to CFO 01/19/23 Cyteir Therapeutics announces prioritization of CYT-0851 development 03/23/23 Torrid names Mark Mizicko as Chief Commercial Officer 12/16/22 Torrid rises 9.9% 12/09/22 Torrid falls -15.7% 12/09/22 Torrid falls -19.0% 02/15/23 Jefferies Torrid downgraded to Hold from Buy at Jefferies 12/09/22 William Blair William Blair downgrades Torrid on larger than thought overhang 12/09/22 Morgan Stanley Torrid assumed with an Equal Weight at Morgan Stanley 12/09/22 William Blair Torrid downgraded to Market Perform from Outperform at William Blair 08/11/22 DA Davidson OppFi cut to Neutral at DA Davidson yesterday after pulling FY22 profit outlook 08/10/22 DA Davidson OppFi downgraded to Neutral from Buy at DA Davidson 06/15/22 Evercore ISI Crinetics added to Best SMID 'Core' Ideas list at Evercore ISI 05/10/22 Cantor Fitzgerald Heron Therapeutics price target lowered to $12 from $20 at Cantor Fitzgerald 05/10/22 TD Cowen Heron Therapeutics price target lowered to $7.50 from $13 at Cowen 11/07/22 Canaccord Regulus initiated with a Buy at Canaccord 02/24/23 Goldman Sachs Erasca initiated with a Buy at Goldman Sachs 02/03/23 Morgan Stanley Erasca upgraded to Overweight from Equal Weight at Morgan Stanley 02/03/23 Morgan Stanley Cyteir downgraded to Underweight from Equal Weight at Morgan Stanley 01/30/23 BofA Cyteir Therapeutics downgraded to Neutral at BofA after strategic prioritization 01/30/23 BofA Cyteir Therapeutics downgraded to Neutral from Buy at BofA 01/20/23 JPMorgan Cyteir Therapeutics downgraded to Neutral from Overweight at JPMorgan 02/07/23 JPMorgan Southwest Gas price target lowered to $75 from $78 at JPMorgan 12/14/22 Wells Fargo Southwest Gas price target raised to $73 from $66 at Wells Fargo 11/30/22 BofA Southwest Gas downgraded to Neutral at BofA as strategic review 'drags on' 11/30/22 BofA Southwest Gas downgraded to Neutral from Buy at BofA 04/18/22 EF Hutton Quest Resource initiated with a Buy at EF Hutton 12/07/22 Citi Ouster downgraded to Neutral from Buy at Citi 11/09/22 Oppenheimer Velodyne Lidar downgraded to Perform from Outperform at Oppenheimer 11/09/22 Craig-Hallum Velodyne Lidar upgraded to Hold from Sell at Craig-Hallum 11/08/22 Baird Ouster downgraded to Neutral from Outperform at Baird 01/30/23 KeyBanc Oxford Industries price target raised to $130 from $125 at KeyBanc 12/08/22 CL King Oxford Industries price target raised to $140 from $137 at CL King 12/08/22 Citi Oxford Industries price target raised to $110 from $105 at Citi 09/21/22 Citi Oxford Industries upgraded to Neutral from Sell at Citi 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 08/31/22 BofA BofA downgrades Joann to Underperform on signs of slowing arts & crafts demand RLMD Relmada Therapeutics 12/08/22 Truist Relmada Therapeutics price target lowered to $4 from $7 at Truist 11/11/22 SVB Securities Relmada 'still has a chance' for positive depression data, says SVB 10/14/22 BofA Axsome shares could react positively to Relmada trial failure, says BofA 10/14/22 Goldman Sachs Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs 02/28/23 Southwest Gas reports Q4 adjusted EPS $1.16, consensus $1.58 11/09/22 Southwest Gas reports Q3 adjusted EPS (5c), consensus 27c 03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago RLMD Relmada Therapeutics 03/23/23 Relmada Therapeutics reports Q4 EPS ($1.28), consensus ($1.33) 11/10/22 Relmada Therapeutics reports Q3 EPS ($1.31), consensus ($1.45) 03/23/23 Regulus reports Q4 EPS (40c), consensus (51c) 11/10/22 Regulus reports Q3 EPS (50c), consensus (49c) 03/23/23 Quest Resource reports Q4 EPS (2c), consensus (5c) 11/14/22 Quest Resource reports Q3 EPS 4c, consensus (3c) 03/23/23 Oxford Industries sees FY23 adjusted EPS $11.50-$11.90, consensus $11.82 03/23/23 Oxford Industries sees Q1 adjusted EPS $3.60-$3.80, consensus $4.10 03/23/23 Oxford Industries reports Q4 adjusted EPS $2.28, consensus 12/07/22 Oxford raises FY22 adjusted EPS view to $10.60-$10.75 from $10.25-$10.60 03/23/23 Ouster sees Q1 revenue $15M-$17M, consensus $20.1M 03/23/23 Ouster reports Q4 EPS (23c), consensus (18c) 11/07/22 Ouster backs FY22 revenue view $40M-$55M, consensus $46.14M 11/07/22 Ouster reports Q3 EPS (20c), consensus (17c) 03/23/23 OppFi sees FY23 adjusted EPS 26c-33c, consensus 24c 03/23/23 OppFi reports Q4 adjusted EPS (19c), consensus (10c) 11/09/22 OppFi backs FY22 revenue growth view 20%-25%, consensus $429.57M 11/09/22 OppFi reports Q3 adjusted EPS 1c, consensus (6c) 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c 03/23/23 Heron Therapeutics reports Q4 EPS (17c), consensus (28c) 11/08/22 Heron Therapeutics reports Q3 EPS (38c), consensus (38c) 03/23/23 Erasca reports Q4 EPS ($1.06) vs. (26c) last year 11/09/22 Erasca reports Q3 EPS (29c), consensus (31c) 03/23/23 Eargo reports Q4 EPS ($4.18) vs ($17.11) last year 03/23/23 Cyteir Therapeutics reports Q4 EPS (25c), consensus (34c) 11/07/22 Cyteir Therapeutics reports Q3 EPS (31c), consensus (41c) 03/23/23 Torrid sees FY23 revenue $$.125B-$1.32B, consensus $1.26B 03/23/23 Torrid sees Q1 revenue $305M-$313M, consensus $315.6M 03/23/23 Torrid reports Q4 EPS (4c), consensus (8c) 12/08/22 Torrid cuts FY22 revenue view to $1.244B-$1.259B from $1.26B-$1.3B
Hot Stocks
Show Hide Related Items >> <<
03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 11/23/22 Scholastic reports preliminary results of modified Dutch Auction tender offer 03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago
Earnings
Cuts FY23 adjusted EBITDA…
Cuts FY23 adjusted EBITDA view to $175M-$185M from $195M-$205M.
Show Hide Related Items >> <<
03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 11/23/22 Scholastic reports preliminary results of modified Dutch Auction tender offer 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago
Hot Stocks
The company's Board…
The company's Board of Directors has authorized an additional $50M for repurchases of its common stock under the company's stock repurchase program. This authorization increases the aggregate amount of shares, in dollar terms, which may now be repurchased to over $75M.
Show Hide Related Items >> <<
02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 11/23/22 Scholastic reports preliminary results of modified Dutch Auction tender offer 10/25/22 Scholastic announces cash tender offer to purchase up to $75M in common stock 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago
Earnings
Reports Q3 revenue…
Reports Q3 revenue $324.9M vs. $344.5M last year.
Show Hide Related Items >> <<
02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 11/23/22 Scholastic reports preliminary results of modified Dutch Auction tender offer 10/25/22 Scholastic announces cash tender offer to purchase up to $75M in common stock 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago
